Aligos Therapeutics, Inc.
ALGS
$10.20
$0.363.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.05% | 22.28% | -58.04% | 6.38% | 4.07% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -0.70% | 0.36% | -3.31% | 16.28% | 47.84% |
| Total Current Assets | 28.50% | 21.29% | -55.95% | 6.94% | 5.65% |
|
|
|||||
| Total Current Assets | 28.50% | 21.29% | -55.95% | 6.94% | 5.65% |
| Net Property, Plant & Equipment | -28.90% | -25.52% | -25.38% | -24.72% | -23.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.43% | 1.12% | 0.32% | 1.93% | 1.12% |
| Total Assets | 23.80% | 17.82% | -53.74% | 3.00% | 2.53% |
|
|
|||||
| Total Accounts Payable | -42.26% | 56.93% | 2.15% | -6.83% | 110.40% |
| Total Accrued Expenses | 1.20% | -8.65% | -7.63% | 14.92% | -12.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.51% | 6.51% | 6.76% | 4.45% | 3.65% |
| Total Finance Division Other Current Liabilities | -56.33% | -- | -88.46% | -83.42% | -80.93% |
| Total Other Current Liabilities | -56.33% | -- | -88.46% | -83.42% | -80.93% |
| Total Current Liabilities | -14.00% | 0.36% | -9.07% | -6.73% | -13.45% |
|
|
|||||
| Total Current Liabilities | -14.00% | 0.36% | -9.07% | -6.73% | -13.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -48.50% | -39.16% | -37.75% | -32.69% | -29.37% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.93% | -74.01% | 161.97% | 25,206.52% | 12,304.30% |
| Total Liabilities | -21.02% | -49.70% | 66.65% | 23.52% | 13.94% |
|
|
|||||
| Common Stock & APIC | 18.67% | 18.92% | 1.77% | 14.06% | 14.38% |
| Retained Earnings | -14.36% | -10.21% | -26.95% | -16.77% | -17.18% |
| Treasury Stock & Other | -14.98% | -6.09% | -17.25% | 16.10% | -0.60% |
| Total Common Equity | 51.52% | 94.74% | -131.47% | -8.62% | -3.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 51.52% | 94.74% | -131.47% | -8.62% | -3.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 51.52% | 94.74% | -131.47% | -8.62% | -3.46% |
|
|
|||||